Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia

The ability to detect residual levels of leukemic blasts (measurable residual disease, MRD) has already been integrated in the daily routine for treatment of patients with chronic myeloid and acute lymphoblastic leukemia. In acute myeloid leukemia (AML), a variety of mostly retrospective studies hav...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Jentzsch, Madlen, Schwind, Sebastian, Bach, Enrica, Stasik, Sebastian, Thiede, Christian, Platzbecker, Uwe
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6893483/
https://ncbi.nlm.nih.gov/pubmed/31652787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11111625
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki